Table 2.
Variable | Calcium group (n = 20) | Placebo group (n = 20) | P value | ||||
---|---|---|---|---|---|---|---|
Baseline | 12th week | 24th week | Baseline | 12th week | 24th week | ||
Weight (kg) | 77.65 ± 16.87 | 75.00 ± 16.74 | 73.60 ± 17.04 | 76.25 ± 8.23 | 74.70 ± 8.74 | 73.20 ± 9.18 | 0.870 |
WC (cm) | 89.40 ± 11.02 | 86.55 ± 10.97 | 85.10 ± 11.12 | 87.65 ± 7.74 | 85.20 ± 7.57 | 83.90 ± 7.58 | 0.633 |
HC (cm) | 107.85 ± 8.23 | 105.70 ± 8.10 | 104.15 ± 8.30 | 108.65 ± 5.74 | 106.75 ± 6.35 | 105.20 ± 6.18 | 0.672 |
Glucose (mg/dl) | 85.40 ± 4.84 | 75.55 ± 7.85 | 71.20 ± 8.53 | 86.60 ± 7.65 | 77.60 ± 7.55 | 73.55 ± 8.36 | 0.364 |
Insulin (mIU/ml) | 6.17 ± 3.24 | 2.62 ± 3.83 | 6.88 ± 3.29 | 4.86 ± 3.42 | 4.14 ± 2.84 | 5.15 ± 3.87 | 0.510 |
Fatmass (kg) | 26.98 ± 7.36 | 24.40 ± 6.48 | 23.66 ± 7.12 | 26.86 ± 6.27 | 25.47 ± 6.33 | 24.56 ± 7.06 | 0.773 |
Leanmass (kg) | 50.67 ± 13.39 | 50.98 ± 13.16 | 50.18 ± 13.47 | 49.38 ± 6.09 | 49.22 ± 6.47 | 48.69 ± 6.04 | 0.647 |
BP (systol) (mmHg) | 11.25 ± 0.96 | 11.35 ± 0.58 | 11.0 ± 0.85 | 11.32 ± 1.07 | 11.05 ± 0.82 | 10.58 ± 0.82 | 0.540 |
BP (diastol) (mmHg) | 7.50 ± 0.76 | 7.75 ± 0.91 | 7.25 ± 0.85 | 7.62 ± 0.88 | 7.60 ± 0.82 | 7.35 ± 0.67 | 0.900 |
All values are mean ± SD.
There were no significant differences between groups in 3 stages of the study (general linear model).